翻訳と辞書 |
FTC v. Actavis, Inc. : ウィキペディア英語版 | FTC v. Actavis, Inc.
''FTC v. Actavis, Inc.'', 570 U.S. ___ (2013), was a United States Supreme Court case that questioned the relationship between patent law and antitrust law. The question at hand was whether it was illegal for brand-name manufacturers to use reverse payment settlements to keep would-be generic competitors out of the market, even if the brand-name drug company held a legal limited monopoly in the form of a patent. While the Court refused to declare that such settlements were presumptively illegal, it did rule 5-3 that the Federal Trade Commission (FTC) could not be prevented from bringing antitrust action against the defendants to try for the unlawfulness of the reverse payment settlement. 〔(FTC v. Actavis, Inc. ) 570 U.S. ___ (2013).Retrieved 20 October 2013.〕 == Background ==
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「FTC v. Actavis, Inc.」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|